Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ventrus Announces Improved, FDA-Recommended Endpoints Proposed for Phase III Hemorrhoid Study
Yahoo/GlobeNewsWire
Saturday, March 19, 2011 - 10:10am
tags:
Ventrus, hemorrhoids, iferanserin
Glaxo Diabetes Candidate Disappoints
Yahoo/Zacks
Saturday, March 19, 2011 - 10:08am
tags:
GSK, otelixizumab, Tolerx, DEFEND-1, diabetes
Low-Priced Biotech Stocks With Insider Buying
Seeking Alpha
Saturday, March 19, 2011 - 10:06am
tags:
Ligand, Dyax, Bioclinica, Synta Pharmaceuticals, Threshold Pharmaceuticals, Chelsea Therapeutics, Alimera, Cerus
Illumina Closes $800 Million Convertible Senior Notes
Yahoo/BusinessWire
Saturday, March 19, 2011 - 10:04am
tags:
Illumina
EMA Says Possible Shortage of Genzyme’s Thyrogen Medicine
Bloomberg
Saturday, March 19, 2011 - 10:03am
tags:
Genzyme, Thyrogen
Sanofi Inks Deal with Genfit
Yahoo/Zacks
Saturday, March 19, 2011 - 10:02am
tags:
Sanofi, Genfit
Affymax in $50M stock sale
bizjournals.com
Saturday, March 19, 2011 - 10:00am
tags:
Affymax
Bristol-Myers Squibb: PDUFA Date Looms for Ipilimumab
Seeking Alpha
Saturday, March 19, 2011 - 9:59am
tags:
Bristol-Myers Squibb, PDUFA, ipilimumab, immunotherapy, Provenge, monoclonal antibodies
Human Genome Pumps Up Its Pipeline
Seeking Alpha
Saturday, March 19, 2011 - 9:58am
tags:
Human Genome Sciences, FP-1039, Benlysta
Bristol-Myers Bribed Doctors, California Commissioner Says
Bloomberg
Friday, March 18, 2011 - 8:00pm
tags:
whistleblowers, Bristol-Myers Squibb, California, bribery, kickbacks
J&J, U.S. Sue Teva to Block Generic Version of Prezista HIV Drug
Bloomberg
Friday, March 18, 2011 - 7:59pm
tags:
JNJ, Teva Pharmaceuticals, Prezista, HIV, generics
Pfizer brings new chewable Viagra to Mexico
Reuters
Friday, March 18, 2011 - 11:06am
tags:
Pfizer, Viagra, Mexico, erectile dysfunction
FDA asks for training program on Lilly's Amyvid
Yahoo/AP
Friday, March 18, 2011 - 11:00am
tags:
Eli Lilly, Amyvid, Alzheimer's disease
Genomics companies finally bear fruit
Fierce Biotech
Friday, March 18, 2011 - 10:24am
tags:
genomics, Daiichi Sankyo, Illumina, Life Technologies, Pacific Biosciences
EMA Recommends Approval for Pfizer, Bristol-Myers’ Eliquis
Bloomberg
Friday, March 18, 2011 - 10:22am
tags:
EMA, Europe, Eliquis, Pfizer, blood thinners, Apixaban
Zimmer, Biomet, Nobel Said to Be Among Bidders for Astra Tech
Bloomberg
Friday, March 18, 2011 - 9:11am
tags:
Zimmer, Biomet, dental, Nobel Biocare, Astra Tech, M&A
No Desk, No Chair: Glaxo to Torture Staffers By Abolishing Personal Workspaces
BNET Pharma
Friday, March 18, 2011 - 9:09am
tags:
GSK
Quest to Buy Celera for $344 Million
TheStreet.com
Friday, March 18, 2011 - 9:04am
tags:
M&A, Celera, Quest Diagnostics
Vertex's Treatment for Cystic Fibrosis
Bloomberg Businessweek
Friday, March 18, 2011 - 9:03am
tags:
cystic fibrosis, Vertex Pharmaceuticals, VX-770
Actelion’s Hiring of Goldman May Lead to Sale, Vontobel Says
Bloomberg
Friday, March 18, 2011 - 9:02am
tags:
Actelion, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.